A Patent Fight Over The World’s Top-Selling Drug

In this week’s edition of InnovationRx, we look at a patent fight over the world’s top-selling drug, breakthroughs from the American Association for Cancer Research, Verily’s Parkinson’s dataset, the relationship between microplastics and heart disease, and more. To get it in your inbox, subscribe here.

Merck’s Keytruda is the world’s top-selling drug, bringing in nearly $30 billion in sales last year. The drug, which is used to treat…